Exploring the Anticancer Potential of the Multistrain Probiotic Formulation OxxySlab in Bladder Cancer Cell Lines
Open Access
- 26 October 2025
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 14 (11) , 1282
Abstract
Bladder cancer (BC), particularly its muscle-invasive subtype (MIBC), remains a clinical challenge due to high recurrence and limited therapeutic options. Emerging evidence suggests that probiotics may offer selective anticancer effects while preserving healthy tissue. In this study, we evaluated the antitumor potential of OxxySlab, a multistrain probiotic formulation, in two BC cell lines (T24 and 5637) and a non-tumorigenic urothelial cell line (SV-HUC1). OxxySlab lysate dose-dependently inhibited BC cell proliferation, clonogenicity, and migration, while sparing normal cells. Mechanistically, the treatment suppressed epithelial–mesenchymal transition (EMT), induced senescence, and disrupted redox homeostasis in malignant cells. These effects were associated with the induction of oxidative stress and impaired antioxidant defenses. Co-treatment with vitamin C attenuated ROS accumulation and senescence, implicating oxidative stress as a key mediator. Notably, SV-HUC1 cells retained viability and phenotype, confirming the formulation’s selectivity. Overall, these findings support OxxySlab as a promising adjunctive strategy in BC therapy, capable of reducing tumor aggressiveness through redox-mediated senescence and EMT inhibition without harming normal urothelial cells.Keywords
Funding Information
- Università degli Studi dell'Aquila (06VITALITY_PALUMBO)
This publication has 39 references indexed in Scilit:
- Bladder cancer biomarker analysis and drugtarget prediction based on pyroptosis-related genesDiscover Oncology, 2025
- Urobiome and Inflammation: A Systematic Review on Microbial Imbalances and Diagnostic Tools for Urinary DisordersUrology, 2025
- The bacterial microbiome and cancer: development, diagnosis, treatment, and future directionsClinical and Experimental Medicine, 2024
- A review of urinary bladder microbiome in patients with bladder cancer and its implications in bladder pathogenesisWorld Journal of Urology, 2024
- Wnt/β-catenin-driven EMT regulation in human cancersCellular and Molecular Life Sciences, 2024
- The effects of probiotics on reducing the colorectal cancer surgery complications: A periodic review during 2007–2017Clinical Nutrition, 2020
- Tumorsphere assay provides a better in vitro method for cancer stem-like cells enrichment in A549 lung adenocarcinoma cellsTissue and Cell, 2019
- Migration versus proliferation as contributor to in vitro wound healing of vascular endothelial and smooth muscle cellsExperimental Cell Research, 2019
- SLAB51 Probiotic Formulation Activates SIRT1 Pathway Promoting Antioxidant and Neuroprotective Effects in an AD Mouse ModelMolecular Neurobiology, 2018
- Prevention of Recurrence With Epirubicin and Lactobacillus Casei After Transurethral Resection of Bladder CancerJournal of Urology, 2008